Wednesday, May 16, 2012

AZ starts Operation Atilla!

First wave of AstraZeneca's CNS R&D group gets the ax

AstraZeneca isn't wasting any time in pushing ahead with draconian cuts to its neuroscience work in its big R&D hub south of Stockholm. The first 50 scientists have already been shown the door, according to local news reports, part of the first wave of 400 job cuts as AstraZeneca ($AZN) slashes a total of 1,100 positions at the research complex.

No comments: